0001493152-24-046765.txt : 20241119
0001493152-24-046765.hdr.sgml : 20241119
20241119143727
ACCESSION NUMBER: 0001493152-24-046765
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20241108
FILED AS OF DATE: 20241119
DATE AS OF CHANGE: 20241119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BELL LON E
CENTRAL INDEX KEY: 0000941593
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42204
FILM NUMBER: 241475400
MAIL ADDRESS:
STREET 1: C/O AMERIGON INC
STREET 2: 5462 IRWINDALE AVENUE
CITY: IRWINDALE
STATE: CA
ZIP: 91706
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Invizyne Technologies Inc
CENTRAL INDEX KEY: 0002010788
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 834550057
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 ROYAL OAKS DR
CITY: MONROVIA
STATE: CA
ZIP: 91016
BUSINESS PHONE: (626) - 415 - 1488
MAIL ADDRESS:
STREET 1: 750 ROYAL OAKS DR
CITY: MONROVIA
STATE: CA
ZIP: 91016
3
1
ownership.xml
X0206
3
2024-11-08
0
0002010788
Invizyne Technologies Inc
IZTC
0000941593
BELL LON E
C/O 750 ROYAL OAKS DRIVE,
SUITE 106
MONROVIA,
CA
91016
1
0
0
0
Stock Options for Common Stock
8.00
2025-07-01
2031-03-31
Common Stock
51939
D
The options vest as follows: The first 10,392 shares vest on July 1, 2025, and the balance vest at the rate of 2,598 shares per quarter, commencing on October 1, 2024 and become exercisable once vested. All shares are vested by 03/31/2029
/s/ Lon Edward Bell
2024-11-18